Watch our latest video

Ep. 10: Valuing Vaccines: Ensuring Economic Health & Security for All

Watch Here
News

Flu News Friday, 4/15/2022

Read the latest on influenza vaccines and upcoming funding opportunities in this week’s roundup.

March 2022

Call to Action for World Leaders: Accelerating an Effective and Equitable COVID-19 Response and Pandemic-proofing the Future

Pandemic Action Network, March 25, 2022

The pandemic isn’t over- only 14% of everyone living in low-income countries have received at least one dose of a COVID-19 vaccine. To protect against deadly variants, the Pandemic Action Network and more than 35 endorsing organizations have called on G7 and G20 leaders to invest towards ending this pandemic and preventing the next one. Read the call to strengthen pandemic preparedness systems, diversify funding to address gaps in preparedness, and increase equitable availability of vaccines, diagnostics and therapeutics here.

Read the full article here
March 2022

Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

Dhanasekaran, V., Sullivan, S., Edwards, K.M. et al. (2022). Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat Commun 13(1721).

As lack of exposure to influenza reduces population immunity, future seasonal influenza outbreaks may be more severe than those prior to the COVID-19 pandemic. During the 2020-2021 influenza season, lineages such as B/Yamagata largely disappeared due to low influenza infection rates. However, waning COVID-19 preventative measures and regional vaccine inequities will likely enable many influenza strains to re-emerge, making continued surveillance essential. Learn where influenza was detected during the 2020-2021 influenza season and the history of influenza circulation here.

Read the full article here
April 2022

New crop of covid-19 mrna vaccines could be easier to store, cheaper to use

Cohen, J. (2022, April 5). New crop of covid-19 mrna vaccines could be easier to store, cheaper to use. Science.

More than 15 new COVID-19 mRNA vaccines are advancing into clinical studies, many of which would be easier to store and lower in price than the first generation of COVID-19 mRNA vaccines. While clinical studies are challenging due to ethical concerns and low levels of an unexposed public, these vaccines could dramatically increase global access to mRNA technology. Read more about these promising candidates here.

Read the full article here
April 2022

Applications Close April 15, 2022 for the 4th International Workshop on Participatory Surveillance

Applications for the 4th International Workshop on Participatory Surveillance (IWOPS) close April 15th– today! This workshop hosted by Ending Pandemics will be held in Phnom Penh, Cambodia from October 31-November 3, 2022 and will convene global experts to establish data standards, integrate new technologies, explore disease modeling and more. To participate in improving community engagement towards human, animal and environmental health globally, apply here.

Read more about the workshop here

Funding Opportunities & Announcements

  • Research on the Epidemiology, Prevention and Control of Influenza and Other Respiratory Viruses in India (Link) [Discretionary Grant]       CDC-ERA / March 8, 2022 / May 4, 2022

  • US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings (Link) [Discretionary Grant]                         CDC- ERA / March 17, 2022 / May 9, 2022

  • Postdoctoral Clinical Fellows (Link) [Fellowship]                                            The Francis Crick Institute / March 14, 2022 / April 29, 2022

  • Tribal Epidemiology Centers Public Health Infrastructure (Link) [Discretionary Grant]                                                                                              CDC- NCCDPHP / April 5, 2022 / May 11, 2022

  • Apply for Mini-Funds to Encourage Open Science Practices in Influenza Research [Link] [Grants]                                                                           Center for Open Science and Flu Lab / Open